Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

March 30, 2026

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

March 30, 2026

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 – Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

March 30, 2026

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

March 30, 2026

Trends and Opportunities in the Chemotherapy-At-Home Services Market, 2026-2030: Total Revenue to Grow by $1 Billion, Led by CVS Health, Optum, and Fresenius Kabi

March 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » United Kingdom Atomic Energy Authority and Canadian Nuclear Laboratories Partner to Accelerate Fusion Energy Development
Press Release

United Kingdom Atomic Energy Authority and Canadian Nuclear Laboratories Partner to Accelerate Fusion Energy Development

By News RoomFebruary 14, 20247 Mins Read
United Kingdom Atomic Energy Authority and Canadian Nuclear Laboratories Partner to Accelerate Fusion Energy Development
Share
Facebook Twitter LinkedIn Pinterest Email

OXFORD, United Kingdom and CHALK RIVER, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) — The United Kingdom Atomic Energy Authority (UKAEA) and Canadian Nuclear Laboratories (CNL), have signed a collaboration framework agreement to partner on the development of technologies in relation to the management of tritium, a fusion energy fuel.

This agreement complements the signing today of a Memorandum of Understanding by the UK’s Energy Secretary, Claire Coutinho and Canadian Minister of Energy and Natural Resources, Jonathan Wilkinson at the International Energy Agency’s (IEA) Ministerial meeting.

The UK-Canada Memorandum of Understanding enhances collaboration on key focus areas, including research and development, regulatory harmonisation, and skills and workforce development.

Stephen Wheeler, UKAEA Executive Director, said: “Fusion energy promises to be a safe, low carbon and sustainable part of the world’s future energy supply. Tritium is a key fuel for fusion energy, and developing a commercial scale fuel cycle for the handling and reprocessing of tritium is vital to the delivery of fusion as a clean energy source.”

“This collaboration between UKAEA and CNL brings together two of the largest and most experienced tritium research and operational teams in order to accelerate the development of new technologies for tritium processing,” added Wheeler.

A key focus of the partnership will be on hydrogen isotope management within the fusion fuel cycle safely removing, processing, and reinjecting fuel to the plasma in a continuous manner. Hydrogen isotope management is an essential part of the fusion fuel cycle – tritium needs to be separated from other hydrogen isotopes in the exhaust gas so that it can be recycled and reused as a fusion fuel. Tritium is rare in nature, so managing tritium efficiently is crucial to fusion energy’s commercial viability.

The first project under this collaboration will involve samples of candidate materials for isotope separation being analysed at both CNL’s facilities in Chalk River, Ontario, and UKAEA’s facilities in Culham, Oxfordshire.

“CNL has a proud history of working alongside the United Kingdom to advance clean energy technologies, and this agreement builds on that relationship, to pursue fusion technologies, a transformative clean energy solution for our respective countries,” commented Jeff Griffin, Vice-President, Science and Technology, CNL.

“For our part, CNL has extensive expertise in the safe operation of facilities, storage and management of tritium, capabilities that will be critically important to this collaboration. Overall, we are thrilled to work with such a talented and internationally respected team of researchers at the UKAEA, and we cannot wait to get started,” remarked Ian Castillo, Head of Hydrogen and Tritium Technologies, CNL.

The UK-Canada collaboration builds on the announcement of the UK-US Strategic Partnership on Fusion Energy in November 2023 and will support the UK’s £650 million Fusion Futures programme, which is ensuring the UK remains at the cutting-edge of innovation – with training opportunities and dedicated funding for fusion companies. 

The UKAEA and CNL agreement establishes a framework in which the two organisations will conduct joint research projects, facilitate personnel secondments, share expertise for consultancy services, and work together to provide services to the fusion industry.

Both UKAEA and CNL facilities will also be leveraged in this partnership to advance tritium technologies required for fusion applications, including the design of tritium processing plants, tritium-compatible materials development, tritium breeder blanket technologies, tritium decontamination, and analytical equipment and the modeling of tritium handling processes.

Photos

Photos from a recent visit Canadian Nuclear Laboratories visit to UK Atomic Energy Authority’s Culham Campus, in Oxfordshire, can be found here: https://ukaea.canto.global/b/JTQVC

About UK Atomic Energy Authority

United Kingdom Atomic Energy Authority (UKAEA) is the UK’s national organisation responsible for the research and delivery of sustainable fusion energy. It is an executive non-departmental public body, sponsored by the Department for Energy Security and Net Zero.

Fusion energy has great potential to deliver safe, sustainable, low carbon energy for generations to come. It is based on the same processes that power the Sun and stars, and would form part of the world’s future energy mix. Achieving this is a major technical challenge that involves working at the forefront of science, engineering, and technology.

UKAEA’s fusion machines include MAST-Upgrade (Mega Amp Spherical Tokamak) and the JET (Joint European Torus) research facility. JET’s operations were funded by the UK Government from 2021 until 31st December 2023. UKAEA is delivering the transition of JET from plasma operations to repurposing and decommissioning, on behalf of the UK Government. The insights gained from this process will contribute to the advancement of sustainable future fusion powerplants. 

UKAEA is implementing the UK’s £650 million Fusion Futures Programme, the UK’s alternative programme to associating to Euratom R&T, to support the UK Fusion Strategy. The Programme entails establishing new facilities at UKAEA’s Culham Campus in Oxfordshire to facilitate the advancement of new technologies and expand fusion fuel cycle capabilities. The Programme aims to foster world-leading innovation while also stimulating general industry capacity through international collaboration and the development of future fusion power plants. Additionally, a fusion skills package will be introduced focusing on nurturing expertise across a spectrum of disciplines and levels. In 2021, UKAEA opened its Fusion Technology Facility near Rotherham in South Yorkshire, to develop and test materials and components for future fusion powerplants.

UKAEA also undertakes cutting edge work with academia, other research organisations and the industrial supply chain in a wide spectrum of areas, including robotics and materials.

More information: https://www.gov.uk/ukaea. Social Media: @UKAEAofficial

About fusion energy

When a mix of two forms of hydrogen (deuterium and tritium) is heated to form a controlled plasma at extreme temperatures – 10 times hotter than the core of the Sun – they fuse together to create helium and release energy which can be harnessed to produce electricity. There is more than one way of achieving this. UKAEA’s approach is to hold this hot plasma using strong magnets in a ring-shaped machine called a ‘tokamak’, and then to harness this heat to produce electricity in a similar way to existing power stations.

About CNL

As Canada’s premier nuclear science and technology laboratory, and working under the direction of Atomic Energy of Canada Limited (AECL), CNL is a world leader in the development of innovative nuclear science and technology products and services. This includes a long and extensive history in the development and deployment of technologies and systems to safely manage hydrogen isotopes, including deuterium and tritium. CNL operates a state-of-the-art Tritium Facility, licensed to handle large quantities of tritium, and another one-of-a-kind facility for technologies at the Chalk River Laboratories campus.

CNL is also expanding its presence in fusion as part of its clean energy program. Working with one of its key partners, Kyoto Fusioneering, CNL is currently exploring plans to establish an internationally-unique flexible fusion fuel cycle and demonstration platform at the Chalk River campus for national and international fusion communities’ involvement. This is in addition to a series of projects that CNL recently announced demonstrating its growing momentum in this emerging clean energy space, including partnerships with First Light Fusion and General Fusion with whom a MOU has been signed.

Guided by an ambitious corporate strategy known as Vision 2030, CNL fulfills three strategic priorities of national importance – restoring and protecting the environment, advancing clean energy technologies, and contributing to the health of Canadians.

By leveraging the assets owned by AECL, CNL also serves as the nexus between government, the nuclear industry, the broader private sector and the academic community. CNL works in collaboration with these sectors to advance innovative Canadian products and services towards real-world use, including carbon-free energy, cancer treatments and other therapies, non-proliferation technologies and waste management solutions.

For more information on CNL, including its various clean energy projects and programs, please visit www.cnl.ca.

CNL Contact:
Philip Kompass
Director, Corporate Communications
1-866-886-2325
[email protected]

Media contacts for the UK Atomic Energy Authority [email protected]  

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/6f1033f4-6402-4972-99aa-0872b1269740

https://www.globenewswire.com/NewsRoom/AttachmentNg/78a0679d-1675-4042-a80b-b6bc7552bf91

https://www.globenewswire.com/NewsRoom/AttachmentNg/6dc7fce3-d7c7-475e-ac74-6bdc285bb07a

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 – Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

Trends and Opportunities in the Chemotherapy-At-Home Services Market, 2026-2030: Total Revenue to Grow by $1 Billion, Led by CVS Health, Optum, and Fresenius Kabi

AI in Oncology for Analytical Solutions Market to Triple in Size During 2026-2030 Registering 34.2% CAGR – IBM Watson Health, NVIDIA Corp., and Siemens Healthineers Dominate the $1.93 Billion Industry

Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030

Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook

Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More

Editors Picks

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

March 30, 2026

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 – Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

March 30, 2026

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

March 30, 2026

Trends and Opportunities in the Chemotherapy-At-Home Services Market, 2026-2030: Total Revenue to Grow by $1 Billion, Led by CVS Health, Optum, and Fresenius Kabi

March 30, 2026

Latest News

AI in Oncology for Analytical Solutions Market to Triple in Size During 2026-2030 Registering 34.2% CAGR – IBM Watson Health, NVIDIA Corp., and Siemens Healthineers Dominate the $1.93 Billion Industry

March 30, 2026

Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030

March 30, 2026

Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook

March 30, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version